230 related articles for article (PubMed ID: 27992564)
1. MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4.
Xiao Y; Zhang X; Fan S; Cui G; Shen Z
PLoS One; 2016; 11(12):e0168078. PubMed ID: 27992564
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a.
Wei L; Yuan M; Zhou R; Bai Q; Zhang W; Zhang M; Huang Y; Shi L
J Cardiovasc Pharmacol; 2015 Apr; 65(4):357-63. PubMed ID: 25850725
[TBL] [Abstract][Full Text] [Related]
5. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
[TBL] [Abstract][Full Text] [Related]
6. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target.
Zhang ZH; Li J; Liu BR; Luo CF; Dong Q; Zhao LN; Zhong Y; Chen WY; Chen MS; Liu SM
J Cardiovasc Pharmacol; 2013 Sep; 62(3):312-9. PubMed ID: 23719092
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload.
Ji Y; Qiu M; Shen Y; Gao L; Wang Y; Sun W; Li X; Lu Y; Kong X
Int J Mol Med; 2018 Apr; 41(4):1909-1916. PubMed ID: 29393356
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
15. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
[TBL] [Abstract][Full Text] [Related]
16. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
Yuan J; Liu H; Gao W; Zhang L; Ye Y; Yuan L; Ding Z; Wu J; Kang L; Zhang X; Wang X; Zhang G; Gong H; Sun A; Yang X; Chen R; Cui Z; Ge J; Zou Y
Theranostics; 2018; 8(9):2565-2582. PubMed ID: 29721099
[No Abstract] [Full Text] [Related]
18. miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1).
Ding Y; Wang J; Lu J
Bioengineered; 2021 Dec; 12(1):6771-6781. PubMed ID: 34515612
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-328 as a regulator of cardiac hypertrophy.
Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
Liu Y; Wang Z; Xiao W
Mol Med Rep; 2016 Sep; 14(3):2860-6. PubMed ID: 27485101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
